Pfizer and King patient assistance update

King is now part of Pfizer, but what does this mean for their patient assistance programs?

On June 29, 2012, the KingKare® program will end and will no longer accept applications. At that time, the following medicines will be added into the Pfizer Helpful Answers® family of patient assistance programs:

  • LEVOXYL® (levothyroxine sodium tablets, USP)
  • SKELAXIN® (metaxalone) Tablets
What should patients do if they need help accessing their Levoxyl and Skelaxin before June 29, 2012?
  • Patients can continue to apply to and use the KingKare program until June 29, 2012.

  • Any medicine orders that are placed through KingKare for eligible patients by June 29, 2012, will be processed and sent to the patient’s healthcare provider, as scheduled.

For assistance with King medicines until June 29, 2012, please contact KingKare directly at 1-866-734-7366.

What should patients do if they need help accessing their Levoxyl and Skelaxin after June 29, 2012?
  • Eligible uninsured and underinsured patients who meet income guidelines can apply to the Pfizer Helpful Answers Connection to Care® program after June 29, 2012, to receive their Levoxyl and Skelaxin for free.
    Patents should plan to apply approximately 1 month before their last KingKare prescription is scheduled to run out.

To learn more about Connection to Care and the application process, click here.

  • Uninsured patients who do not meet the income guidelines for Connection to Care can apply to Pfizer Pfriends® after June 29, 2012, to receive their Levoxyl and Skelaxin at a savings through their pharmacy.

To learn more about Pfizer Pfriends and the application process, click here.

  • Uninsured patients can also continue to save on King medicines through the Together Rx Access® program.

For more information on Together Rx Access, call 1-800-444-4106 or visit www.TogetherRxAccess.com

*Together Rx Access and the Together Rx Access logo are registered trademarks of Together Rx Access, LLC.